AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Lebranchu, Y
Citation: Y. Lebranchu, Chicago 2001 - What to make of Chicago 2001?, PRESSE MED, 30(24), 2001, pp. 3-3

Authors: Lebranchu, Y
Citation: Y. Lebranchu, Allorecognition, PRESSE MED, 30(24), 2001, pp. 31-34

Authors: Mourad, G Garrigue, V Squifflet, JP Besse, T Berthoux, F Alamartine, E Durand, D Rostaing, L Lang, P Baron, C Glotz, D Antoine, C Vialtel, P Romanet, T Lebranchu, Y Al Najjar, A Hiesse, C Potaux, L Merville, P Touraine, JL Lefrancois, N Kessler, M Renoult, E Pouteil-Noble, C Cahen, R Legendre, C Bedrossian, J Le Pogamp, P Rivalan, J Olmer, M Purgus, R Mignon, F Viron, B Charpentier, B
Citation: G. Mourad et al., Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression, TRANSPLANT, 72(6), 2001, pp. 1050-1055

Authors: Halimi, JM Al-Najjar, A Buchler, M Giraudeau, B Etienne, I Picou, S Marliere, J Nivet, H Lebranchu, Y
Citation: Jm. Halimi et al., Microalbuminuria in hypertensive non-proteinuric renal transplant recipients: Role of previous acute rejection episodes and sodium intake, ARCH MAL C, 94(8), 2001, pp. 933-936

Authors: Halimi, JM Lebranchu, Y
Citation: Jm. Halimi et Y. Lebranchu, Regulation and dysfunction of endothelium-dependant vasomotricity: applications in clinical practice, PRESSE MED, 29(38), 2000, pp. 2109-2115

Authors: Watier, H Vallee, I Bardos, P Lebranchu, Y
Citation: H. Watier et al., Anti-pig xenogeneic response by T CD4(+) human lymphocytes., PATH BIOL, 48(4), 2000, pp. 372-376

Authors: Lebranchu, Y
Citation: Y. Lebranchu, Lipids and endothelial dysfunction, NEPHROLOGIE, 21(7), 2000, pp. 373-376

Authors: Halimi, JM Giraudeau, B Vol, S Caces, E Nivet, H Lebranchu, Y Tichet, J
Citation: Jm. Halimi et al., Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population, KIDNEY INT, 58(3), 2000, pp. 1285-1292

Authors: Cappellesso, S Thibault, G Hoarau, C Watier, H Bardos, P Lebranchu, Y
Citation: S. Cappellesso et al., Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelialcells, TRANSPLAN P, 32(8), 2000, pp. 2737-2738

Authors: de Ligny, BH Etienne, I Francois, A Toupance, O Buchler, M Touchard, G Lepogamp, P Comoz, F Lobbedez, T Godin, M Ryckelynck, JP Lebranchu, Y
Citation: Bh. De Ligny et al., Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients, TRANSPLAN P, 32(8), 2000, pp. 2760-2761

Authors: Francois, M Buchler, M Halimi, JM Al-Najjar, A Valentin, JF Thibault, G Lebranchu, Y
Citation: M. Francois et al., Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil, TRANSPLAN P, 32(8), 2000, pp. 2781-2782

Authors: de Ligny, BH Lebranchu, Y
Citation: Bh. De Ligny et Y. Lebranchu, The use of thymoglobuline induction in renal transplantation: A pharmacovigilance study, TRANSPLAN P, 32(2), 2000, pp. 351-352

Authors: Camara, NOS Cappellesso, S Watier, H Lebranchu, Y
Citation: Nos. Camara et al., Endothelial cells provide costimulatory signals to trigger both allogeneicadult and cord blood (NAIVE) CD4+T-cell proliferation, TRANSPLAN P, 32(2), 2000, pp. 355-356

Authors: Lebranchu, Y Aubert, P Bayle, F Bedrossian, J Berthoux, F Bourbigot, B Buchler, M Chalopin, JM Deteix, P Glotz, D De Ligny, BH Kessler, M Lang, P Lefrancois, N Le Pogamp, P Moulin, B Mourad, G Olmer, M Sraer, JD Touchard, G Toupance, O Wolf, P Puget, S
Citation: Y. Lebranchu et al., Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids, TRANSPLAN P, 32(2), 2000, pp. 396-397

Authors: Thervet, E Charpentier, B Durand, D Glotz, D Lebranchu, Y Lefrancois, N Wolf, P
Citation: E. Thervet et al., Early renal function deterioration is the only predictive factor of graft failure after 1 year, TRANSPLAN P, 32(2), 2000, pp. 425-426

Authors: Vanrenterghem, Y Lebranchu, Y Hene, R Oppenheimer, F Ekberg, H
Citation: Y. Vanrenterghem et al., Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection, TRANSPLANT, 70(9), 2000, pp. 1352-1359

Authors: Kreis, H Cisterne, JM Land, W Wramner, L Squifflet, JP Abramowicz, D Campistol, JM Morales, JM Grinyo, JM Mourad, G Berthoux, FC Brattstrom, C Lebranchu, Y Vialtel, P
Citation: H. Kreis et al., Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients, TRANSPLANT, 69(7), 2000, pp. 1252-1260

Authors: Khalfoun, B Barrat, D Watier, H Machet, MC Arbeille-Brassart, B Riess, JG Salmon, H Gruel, Y Bardos, P Lebranchu, Y
Citation: B. Khalfoun et al., Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions, SURGERY, 128(3), 2000, pp. 447-457

Authors: Valentin, JF Lebranchu, Y Nivet, H
Citation: Jf. Valentin et al., Is pig kidney suitable for humans?, NEPHROLOGIE, 20(4), 1999, pp. 189-192

Authors: Lebranchu, Y
Citation: Y. Lebranchu, Control of endothelial activation, a key for chronic rejection?, NEPHROLOGIE, 20(4), 1999, pp. 232-232

Authors: Iochmann, S Reverdiau-Moalic, P Beaujean, S Rideau, E Lebranchu, Y Bardos, P Gruel, Y
Citation: S. Iochmann et al., Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription polymerase chain reaction, THROMB RES, 94(3), 1999, pp. 165-173

Authors: Lebranchu, Y
Citation: Y. Lebranchu, Comparison of two corticosteroid regimens in combination with CellCept andcyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study, TRANSPLAN P, 31(1-2), 1999, pp. 249-250

Authors: Halimi, JM Al-Najjar, A Buchler, M Birmele, B Tranquart, F Alison, D Lebranchu, Y
Citation: Jm. Halimi et al., Transplant renal artery stenosis: Potential role of ischemia/reperfusion injury and long-term outcome following angioplasty, J UROL, 161(1), 1999, pp. 28-32

Authors: Khalfoun, B Sibue, D Bardos, P Lebranchu, Y
Citation: B. Khalfoun et al., Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro, TRANSPLAN P, 30(8), 1998, pp. 3978-3979

Authors: Reverdiau-Moalic, P Watier, H Iochmann, S Pouplard, C Rideau, E Lebranchu, Y Bardos, P Gruel, Y
Citation: P. Reverdiau-moalic et al., Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway, J LA CL MED, 132(6), 1998, pp. 530-540
Risultati: 1-25 |